Company intelligence / Profile preview

Pertinence Invest 2

France

Ownership: Private
Development stage: Other

Overview

Pertinence Invest 2 is a seed/early‑stage investment fund managed by UI Investissement and advised by Mérieux Equity Partners that finances highly innovative technology companies, including healthcare and nutrition, but it does not itself develop drugs or run clinical programs.

Industry: Investors

Partnerships

Mérieux Equity PartnersLeading French engineering schools and universitiesIndustrial sponsors including bioMérieux, Michelin, Seb and others (as part of the Pertinence Invest 2 ecosystem)

Beyond the preview

Go deeper on Pertinence Invest 2.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pertinence Invest 2.

Explore the full profile